Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes

Erin L Heinzen et al. Am J Hum Genet. .

Abstract

Deletions at 16p13.11 are associated with schizophrenia, mental retardation, and most recently idiopathic generalized epilepsy. To evaluate the role of 16p13.11 deletions, as well as other structural variation, in epilepsy disorders, we used genome-wide screens to identify copy number variation in 3812 patients with a diverse spectrum of epilepsy syndromes and in 1299 neurologically-normal controls. Large deletions (> 100 kb) at 16p13.11 were observed in 23 patients, whereas no control had a deletion greater than 16 kb. Patients, even those with identically sized 16p13.11 deletions, presented with highly variable epilepsy phenotypes. For a subset of patients with a 16p13.11 deletion, we show a consistent reduction of expression for included genes, suggesting that haploinsufficiency might contribute to pathogenicity. We also investigated another possible mechanism of pathogenicity by using hybridization-based capture and next-generation sequencing of the homologous chromosome for ten 16p13.11-deletion patients to look for unmasked recessive mutations. Follow-up genotyping of suggestive polymorphisms failed to identify any convincing recessive-acting mutations in the homologous interval corresponding to the deletion. The observation that two of the 16p13.11 deletions were larger than 2 Mb in size led us to screen for other large deletions. We found 12 additional genomic regions harboring deletions > 2 Mb in epilepsy patients, and none in controls. Additional evaluation is needed to characterize the role of these exceedingly large, non-locus-specific deletions in epilepsy. Collectively, these data implicate 16p13.11 and possibly other large deletions as risk factors for a wide range of epilepsy disorders, and they appear to point toward haploinsufficiency as a contributor to the pathogenicity of deletions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
16p13.11 Deletions Observed Exclusively in Epilepsy Patients A total of 23 deletions were observed in the region (indicated by blue bars marking the locations of patient-specific deletions), 22 of them sharing a common segment including or disrupting the NDE1 gene. Deletions in the same patient that were called in tandem and separated only by SNPs that failed genotyping quality control were assumed to be continuous and merged together (shown as a single bar in this display). Using the exact same criteria in controls, we observed no deletions exceeding 16 kb. Segmental duplications flanking the boundaries of these deletions are shown. Figure produced in part with the use of the UCSC Genome Browser.
Figure 2
Figure 2
Confirmation of 16p13.11 Deletions (A) CGH experiment confirming the 16p13.11 deletion. Intensity signals in a single patient with a 16p13.11 deletion detected via PennCNV on Illumina-based genotyping technology (top panel) compared to data collected on the same deletion patient via CGH (Roche NimbleGen, bottom panel). Deletion regions called by the two technologies are shown in red, and the coordinates defining the start and end points of the deletions are provided above each panel. (B) A set of 14 individuals were regenotyped on the Illumina HumanHap 610 genotyping chips for replication of initial calls. All 14 deletions replicated, and the sizes of deletions called were highly correlated. (C) Confirmation of the 16p13.11 deletion with the use of Taqman-based real-time genomic amplification.
Figure 3
Figure 3
Expression Effects of a Subset of 16p13.11 Deletions in Leukocytes (A) Shown is the number of SDs away from the group mean for highly expressed transcripts located within the deletion (red) and a 1 Mb surrounding region (blue). Data are summarized for seven patients with the 16p13.11 deletion (mean ± standard error of the mean) compared to eight controls. (B) Shown is the number of SDs away from the mean for each individual transcript evaluated in individual subjects. The deleted region in each patient is highlighted in yellow. Position of the transcript along the x axis in both panels is equal to the position of the midpoint of the probe measuring the transcript.
Figure 4
Figure 4
Screen for Recessive Variants on the Intact Chromosome of 16p13.11 Individuals with deletions (indicated by the blue bars marking the locations of patient-specific deletions) were selected for a hybridization-based capture and next-generation sequencing experiment in which the intact homologous stretch of chromosome corresponding the deleted segment was sequenced in order to screen for pathogenic recessive mutations that may contribute to the risk associated with the deletion. The average read depth averaged across all ten subjects at each base is shown, and purple bars below mark the regions targeted in the hybridization-based capture. Figure produced in part with the use of the UCSC Genome Browser.
See this image and copyright information in PMC

Similar articles

  • Neuropathology of 16p13.11 deletion in epilepsy.
    Liu JY, Kasperavičiūtė D, Martinian L, Thom M, Sisodiya SM. Liu JY, et al. PLoS One. 2012;7(4):e34813. doi: 10.1371/journal.pone.0034813. Epub 2012 Apr 16. PLoS One. 2012. PMID: 22523559 Free PMC article.
  • Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies.
    de Kovel CG, Trucks H, Helbig I, Mefford HC, Baker C, Leu C, Kluck C, Muhle H, von Spiczak S, Ostertag P, Obermeier T, Kleefuss-Lie AA, Hallmann K, Steffens M, Gaus V, Klein KM, Hamer HM, Rosenow F, Brilstra EH, Trenité DK, Swinkels ME, Weber YG, Unterberger I, Zimprich F, Urak L, Feucht M, Fuchs K, Møller RS, Hjalgrim H, De Jonghe P, Suls A, Rückert IM, Wichmann HE, Franke A, Schreiber S, Nürnberg P, Elger CE, Lerche H, Stephani U, Koeleman BP, Lindhout D, Eichler EE, Sander T. de Kovel CG, et al. Brain. 2010 Jan;133(Pt 1):23-32. doi: 10.1093/brain/awp262. Epub 2009 Oct 20. Brain. 2010. PMID: 19843651 Free PMC article.
  • Male-biased autosomal effect of 16p13.11 copy number variation in neurodevelopmental disorders.
    Tropeano M, Ahn JW, Dobson RJ, Breen G, Rucker J, Dixit A, Pal DK, McGuffin P, Farmer A, White PS, Andrieux J, Vassos E, Ogilvie CM, Curran S, Collier DA. Tropeano M, et al. PLoS One. 2013 Apr 18;8(4):e61365. doi: 10.1371/journal.pone.0061365. Print 2013. PLoS One. 2013. PMID: 23637818 Free PMC article.
  • Epilepsy and the new cytogenetics.
    Mulley JC, Mefford HC. Mulley JC, et al. Epilepsia. 2011 Mar;52(3):423-32. doi: 10.1111/j.1528-1167.2010.02932.x. Epub 2011 Jan 26. Epilepsia. 2011. PMID: 21269290 Free PMC article. Review.
  • Alpha-thalassaemia.
    Bernini LF, Harteveld CL. Bernini LF, et al. Baillieres Clin Haematol. 1998 Mar;11(1):53-90. doi: 10.1016/s0950-3536(98)80070-x. Baillieres Clin Haematol. 1998. PMID: 10872473 Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mefford H.C., Sharp A.J., Baker C., Itsara A., Jiang Z., Buysse K., Huang S., Maloney V.K., Crolla J.A., Baralle D. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med. 2008;359:1685–1699. - PMC - PubMed
    1. Need A.C., Ge D., Weale M.E., Maia J., Feng S., Heinzen E.L., Shianna K.V., Yoon W., Kasperaviciūte D., Gennarelli M. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet. 2009;5:e1000373. - PMC - PubMed
    1. Stefansson H., Rujescu D., Cichon S., Pietiläinen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., GROUP Large recurrent microdeletions associated with schizophrenia. Nature. 2008;455:232–236. - PMC - PubMed
    1. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320:539–543. - PubMed
    1. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., Saemundsen E., Stefansson H., Ferreira M.A., Green T., Autism Consortium Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 2008;358:667–675. - PubMed

Publication types